血清谱分析提示依鲁替尼可用于年轻成人B细胞急性淋巴细胞白血病
BMX、DCTPP1和VGLL4在患者样本中蛋白水平高于健康志愿者,其中BMX涉及BTK通路,提示BTK抑制剂依鲁替尼可能使成人B-ALL患者获益,为未来临床试验提供依据。
要点
- 血清蛋白阵列可表征B-ALL免疫组,鉴定出69个差异抗原。
- BMX在B-ALL患者样本中蛋白水平高于健康志愿者,涉及BTK通路。
- 依鲁替尼或可靶向成人B-ALL,值得开展未来临床试验。
核心结论
- 血清谱分析提示成人B-ALL患者中BMX蛋白水平升高且涉及BTK通路,依鲁替尼可能成为年轻成人B-ALL的治疗选择。
主要发现
- BMX、DCTPP1和VGLL4在患者与健康供者间转录水平无差异,但免疫组化显示其在B-ALL患者样本中蛋白水平高于健康志愿者。
- BMX在Bruton酪氨酸激酶(BTK)通路中起关键作用,可被BTK抑制剂依鲁替尼结合。
临床怎么用
- 提示成人B-ALL(尤其年轻成人)可考虑将依鲁替尼纳入未来临床试验评估。
- 血清蛋白阵列分析有助于表征B-ALL免疫组并发现现有小分子药物的新目标人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute lymphoblastic leukaemia (ALL) is a haematological malignancy that is characterized by the uncontrolled proliferation of immature lymphocytes. 80% of cases occur in children where ALL is well understood and treated. However it has a devastating affects on adults, where multi-agent chemotherapy is the standard of care with allogeneic stem cell transplantation for those who are eligible. New treatments are required to extend remission and prevent relapse to improve patient survival rates. We used serum profiling to compare samples from presentation adult B-ALL patients with age- and sex-matched healthy volunteer (HV) sera and identified 69 differentially recognised antigens (P ≤ 0·02). BMX, DCTPP1 and VGLL4 showed no differences in transcription between patients and healthy donors but were each found to be present at higher levels in B-ALL patient samples than HVs by ICC. BMX plays a crucial role in the Bruton's Tyrosine Kinase (BTK) pathway which is bound by the BTK inhibitor, ibrutinib, suggesting adult B-ALL would also be a worthy target patient group for future clinical trials. We have shown the utility of proto-array analysis of B-ALL patient sera, predominantly from young adults, to help characterise the B-ALL immunome and identified a new target patient population for existing small molecule therapy.
引用
- Jordaens S, Cooksey L, Bonney S, et al. Serum profiling identifies ibrutinib as a treatment option for young adults with B-cell acute lymphoblastic leukaemia. Br J Haematol. 2020. PMID: 32064588. doi:10.1111/bjh.16407
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。